Clinical trial
Multicenter, Post-marketing Observational (Non-interventional) Study to Evaluate the Safety of DAYVIGO Tablet in Patients With Insomnia.
NCT04573556 is registered in ClinicalTrials.gov with Eisai Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicenter, Post-marketing Observational (Non-interventional) Study to Evaluate the Safety of DAYVIGO Tablet in Patients With Insomnia.
- Lead sponsor
- Eisai Co., Ltd.
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 17, 2020
- Completion date
- March 17, 2022
- Enrollment
- 550 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.